186 related articles for article (PubMed ID: 10704147)
1. Expression of Bcl-2 in inflammatory sites from patients with active Behçet's disease.
Hamzaoui K; Hamzaoui A; Zakraoui L; Chabbou A
Mediators Inflamm; 1999; 8(2):101-6. PubMed ID: 10704147
[TBL] [Abstract][Full Text] [Related]
2. NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins.
Todaro M; Zerilli M; Triolo G; Iovino F; Patti M; Accardo-Palumbo A; di Gaudio F; Turco MC; Petrella A; de Maria R; Stassi G
Arthritis Rheum; 2005 Jul; 52(7):2179-91. PubMed ID: 15986355
[TBL] [Abstract][Full Text] [Related]
3. Fas (CD95) and bcl-2 expression in active skin lesions of Behçet's disease.
Bariş YS; Yildiz L; Sentürk N; Kandemir B
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):569-72. PubMed ID: 16164710
[TBL] [Abstract][Full Text] [Related]
4. Diversity of gammadelta T cells in patients with Behcet's disease is indicative of polyclonal activation.
Freysdottir J; Hussain L; Farmer I; Lau SH; Fortune F
Oral Dis; 2006 May; 12(3):271-7. PubMed ID: 16700735
[TBL] [Abstract][Full Text] [Related]
5. Discrepancies of NKT cells expression in peripheral blood and in cerebrospinal fluid from Behçet's disease.
Hamzaoui K; Kamoun M; Houman H; Hentati F; Hamza M; Ayed K; Hamzaoui A
J Neuroimmunol; 2006 Jun; 175(1-2):160-8. PubMed ID: 16624421
[TBL] [Abstract][Full Text] [Related]
6. Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis.
Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
Clin Dev Immunol; 2006; 13(2-4):283-7. PubMed ID: 17162369
[TBL] [Abstract][Full Text] [Related]
7. Tc1/Tc2 ratio in the inflammatory process in patients with Behçet's disease.
Houman H; Hamzaoui A; Ben Ghorbal I; Khanfir MS; Feki M; Hamzaoui K
Mediators Inflamm; 2004 Aug; 13(4):247-53. PubMed ID: 15545055
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of inducible costimulator on peripheral blood CD4+ T cells in Behçet's patients with uveitis: a new activity marker?
Usui Y; Takeuchi M; Yamakawa N; Takeuchi A; Kezuka T; Ma J; Matsuda R; Okunuki Y; Akiba H; Goto H
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5099-104. PubMed ID: 20445113
[TBL] [Abstract][Full Text] [Related]
9. VEGF and mRNA VEGF expression in CSF from Behçet's disease with neurological involvement.
Hamzaoui K; Ayed K; Hamza M; Hamzaoui A
J Neuroimmunol; 2009 Aug; 213(1-2):148-53. PubMed ID: 19493574
[TBL] [Abstract][Full Text] [Related]
10. Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12.
Frassanito MA; Dammacco R; Cafforio P; Dammacco F
Arthritis Rheum; 1999 Sep; 42(9):1967-74. PubMed ID: 10513814
[TBL] [Abstract][Full Text] [Related]
11. Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease.
Geri G; Terrier B; Rosenzwajg M; Wechsler B; Touzot M; Seilhean D; Tran TA; Bodaghi B; Musset L; Soumelis V; Klatzmann D; Cacoub P; Saadoun D
J Allergy Clin Immunol; 2011 Sep; 128(3):655-64. PubMed ID: 21724243
[TBL] [Abstract][Full Text] [Related]
12. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis.
Chi W; Zhu X; Yang P; Liu X; Lin X; Zhou H; Huang X; Kijlstra A
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3058-64. PubMed ID: 18579762
[TBL] [Abstract][Full Text] [Related]
13. Phenotype and functional profile of T cells expressing gamma delta receptor from patients with active Behçet's disease.
Hamzaoui K; Hamzaoui A; Hentati F; Kahan A; Ayed K; Chabbou A; Ben Hamida M; Hamza M
J Rheumatol; 1994 Dec; 21(12):2301-6. PubMed ID: 7699633
[TBL] [Abstract][Full Text] [Related]
14. Levels of IL-15 in serum and cerebrospinal fluid of patients with Behçet's disease.
Hamzaoui K; Hamzaoui A; Ghorbel I; Khanfir M; Houman H
Scand J Immunol; 2006 Dec; 64(6):655-60. PubMed ID: 17083622
[TBL] [Abstract][Full Text] [Related]
15. Micronucleus frequency in the oral mucosa and lymphocytes of patients with Behçet's disease.
Hamurcu Z; Dönmez-Altuntas H; Borlu M; Demirtas H; Asçioslu O
Clin Exp Dermatol; 2005 Sep; 30(5):565-9. PubMed ID: 16045693
[TBL] [Abstract][Full Text] [Related]
16. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
17. Phenotype markers and cytokine intracellular production by CD8+ gammadelta T lymphocytes do not support a regulatory T profile in Behçet's disease patients and healthy controls.
Clemente A; Cambra A; Munoz-Saá I; Crespí C; Pallarés L; Juan A; Matamoros N; Julià MR
Immunol Lett; 2010 Apr; 129(2):57-63. PubMed ID: 20167234
[TBL] [Abstract][Full Text] [Related]
18. Expansion of gammadelta T-cells in Behçet's disease: role of disease activity and microbial flora in oral ulcers.
Bank I; Duvdevani M; Livneh A
J Lab Clin Med; 2003 Jan; 141(1):33-40. PubMed ID: 12518166
[TBL] [Abstract][Full Text] [Related]
19. Increased entry of CD4+ T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behcet's disease.
Koarada S; Haruta Y; Tada Y; Ushiyama O; Morito F; Ohta A; Nagasawa K
Rheumatology (Oxford); 2004 Jul; 43(7):843-51. PubMed ID: 15150429
[TBL] [Abstract][Full Text] [Related]
20. Abnormal expression of chemokine receptors in Behçet's disease: relationship to intracellular Th1/Th2 cytokines and to clinical manifestations.
Houman H; Hamzaoui A; Ben Ghorbal I; Khanfir M; Feki M; Hamzaoui K
J Autoimmun; 2004 Nov; 23(3):267-73. PubMed ID: 15501397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]